AU6492400A - Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene - Google Patents
Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2geneInfo
- Publication number
- AU6492400A AU6492400A AU64924/00A AU6492400A AU6492400A AU 6492400 A AU6492400 A AU 6492400A AU 64924/00 A AU64924/00 A AU 64924/00A AU 6492400 A AU6492400 A AU 6492400A AU 6492400 A AU6492400 A AU 6492400A
- Authority
- AU
- Australia
- Prior art keywords
- 2gene
- polymorphisms
- prostaglandin
- drug target
- endoperoxide synthase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 101150028074 2 gene Proteins 0.000 title 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 title 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 title 1
- 239000003596 drug target Substances 0.000 title 1
- 102000054765 polymorphisms of proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0083—Miscellaneous (1.14.99)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14517099P | 1999-07-22 | 1999-07-22 | |
| US60145170 | 1999-07-22 | ||
| PCT/US2000/020114 WO2001007662A1 (en) | 1999-07-22 | 2000-07-24 | Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2 gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6492400A true AU6492400A (en) | 2001-02-13 |
Family
ID=22511910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU64924/00A Withdrawn AU6492400A (en) | 1999-07-22 | 2000-07-24 | Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6492400A (en) |
| WO (1) | WO2001007662A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004033692A1 (en) * | 2002-10-08 | 2004-04-22 | Bayer Healthcare Ag | Human prostaglandin g/h synthase 2 splice variant |
| CA2873794A1 (en) | 2012-05-16 | 2013-11-21 | Rana Therapeutics Inc. | Compositions and methods for modulating smn gene family expression |
| CN104583401A (en) | 2012-05-16 | 2015-04-29 | Rana医疗有限公司 | Compositions and methods for modulating ATP2A2 expression |
| US10058623B2 (en) * | 2012-05-16 | 2018-08-28 | Translate Bio Ma, Inc. | Compositions and methods for modulating UTRN expression |
| US10837014B2 (en) | 2012-05-16 | 2020-11-17 | Translate Bio Ma, Inc. | Compositions and methods for modulating SMN gene family expression |
| EA201492116A1 (en) | 2012-05-16 | 2015-05-29 | Рана Терапьютикс, Инк. | COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF MECP2 |
| EP2850188A4 (en) | 2012-05-16 | 2016-01-20 | Rana Therapeutics Inc | COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF THE MULTIGENIC FAMILY OF HEMOGLOBIN |
| NO344051B1 (en) * | 2017-05-04 | 2019-08-26 | Patogen As | Novel virus in Fish and Method for detection |
-
2000
- 2000-07-24 AU AU64924/00A patent/AU6492400A/en not_active Withdrawn
- 2000-07-24 WO PCT/US2000/020114 patent/WO2001007662A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001007662A1 (en) | 2001-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2743801A (en) | Sensors with improved properties | |
| ZA200201124B (en) | Humidity controller. | |
| AU3678100A (en) | Biosensor | |
| AU7683700A (en) | Co sensor | |
| EP1116800A4 (en) | Sputtering target | |
| AU2311500A (en) | Position sensing | |
| AU6492400A (en) | Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene | |
| HU9903937D0 (en) | Objective | |
| AU1406401A (en) | Sensor assembly | |
| AU6110700A (en) | Drug target isogenes: polymorphisms in the dopamine receptor d2 gene | |
| AU5848600A (en) | Glass-mounted sensor | |
| AU7388700A (en) | Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene | |
| AU4808200A (en) | Dna balls | |
| AU2000236029A1 (en) | Receptor isogenes: polymorphisms in the tissue necrosis factor receptor | |
| AU6343400A (en) | Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene | |
| AU4098000A (en) | The swinging doggy ball | |
| AU7024700A (en) | Position sensor | |
| AU2000277254A1 (en) | Drug target isogenes: polymorphisms in the interleukin-4 gene | |
| AU2000233075A1 (en) | Dartboard | |
| AU7933700A (en) | Sensors | |
| GB9920137D0 (en) | The blockage buster | |
| GB9916598D0 (en) | The target game | |
| AU2001234807A1 (en) | Drug target isogenes: polymorphisms in the angiotensin receptor 2 gene | |
| AUPQ405399A0 (en) | The stessi catchya | |
| AUPP947599A0 (en) | The rotogyro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |